Fermer le menu


The Technology Research Platform VirNext is a spin-off (EZUS Lyon) of the Université Claude Bernard Lyon 1 (UCBL1), which was created within the VirPath laboratory to foster industrial partnerships and enhance translational research. VirNext offers expertise in the field of respiratory viruses and provides a large panel of technologies, including egg and cell-based processes of virus and vaccine antigen production, and several potency tests using in vitro and in vivo models of infections dedicated to the evaluation of prophylactic and therapeutic candidates.





  • Biotech - Pharma



  • 69 - Rhône